Ionetix Q1 FY26: net loss $16K; diluted EPS $0.00
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001213900-26-059502
Key figures from this report
These are the numbers Ionetix reported for Q1 FY26, the quarter ended Mar 31, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Net income−$16KNo year-earlier figure tagged10-Q income statement, on EDGAR
- Diluted EPS$0.00No year-earlier figure tagged10-Q income statement, on EDGAR
- Cash and cash equivalents$10KNo year-earlier figure tagged10-Q balance sheet, on EDGAR
- Cash from operations−$15KNo year-earlier figure tagged10-Q cash flow statement, on EDGAR
Similar companies
Same SIC code (2835) and public float not reported.
- Burzynski Research Institute BZYR
- Anbio Biotechnology NNNN
- Nymox Pharmaceutical NYMXF
- Asep Medical Holdings SEPSF
- Trinity Biotech TRIB